Preadmission use of antidiabetic medications and mortality among patients with COVID-19 having type 2 diabetes: A meta-analysis
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Preadmission use of antidiabetic medications and mortality among patients with COVID-19 having type 2 diabetes: A meta-analysis
Authors
Keywords
COVID-19, Type 2 diabetes mellitus, Antidiabetic medication
Journal
METABOLISM-CLINICAL AND EXPERIMENTAL
Volume 131, Issue -, Pages 155196
Publisher
Elsevier BV
Online
2022-04-01
DOI
10.1016/j.metabol.2022.155196
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Clinical Characteristics and Risk Factors of Severe COVID-19
- (2021) Jianhua Hu et al. GERONTOLOGY
- Metformin use and risk of COVID-19 among patients with type II diabetes mellitus: an NHIS-COVID-19 database cohort study
- (2021) Tak Kyu Oh et al. ACTA DIABETOLOGICA
- Association Between DPP-4 Inhibitors and COVID-19 Related Outcomes Among Patients With Type 2 Diabetes
- (2021) Yunha Noh et al. DIABETES CARE
- Comparable COVID ‐19 outcomes with current use of GLP ‐1 receptor agonists, DPP ‐4 inhibitors or SGLT ‐2 inhibitors among patients with diabetes who tested positive for SARS‐CoV ‐2
- (2021) Simone Bastrup Israelsen et al. DIABETES OBESITY & METABOLISM
- Predictors of hospital discharge and mortality in patients with diabetes and COVID-19: updated results from the nationwide CORONADO study
- (2021) Matthieu Wargny et al. DIABETOLOGIA
- Association of glycosylated haemoglobin HbA1c levels with outcome in patients with COVID‐19: A Retrospective Study
- (2021) Shuai Yuan et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Association of metformin with susceptibility to COVID-19 in people with Type 2 diabetes
- (2021) Jingya Wang et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Disentangling conflicting evidence on DPP-4 inhibitors and outcomes of COVID-19: narrative review and meta-analysis
- (2021) B. M. Bonora et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Unexpectedly lower mortality rates in COVID-19 patients with and without type 2 diabetes in Istanbul
- (2021) Ilhan Satman et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Risk phenotypes of diabetes and association with COVID-19 severity and death: a living systematic review and meta-analysis
- (2021) Sabrina Schlesinger et al. DIABETOLOGIA
- Cardiometabolic therapy and mortality in very old patients with diabetes hospitalized due to COVID-19
- (2021) Jose Manuel Ramos-Rincón et al. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
- Prescription of glucose-lowering therapies and risk of COVID-19 mortality in people with type 2 diabetes: a nationwide observational study in England
- (2021) Kamlesh Khunti et al. Lancet Diabetes & Endocrinology
- Association Between Glucagon-Like Peptide 1 Receptor Agonist and Sodium–Glucose Cotransporter 2 Inhibitor Use and COVID-19 Outcomes
- (2021) Anna R. Kahkoska et al. DIABETES CARE
- The effect of metformin on mortality and severity in COVID-19 patients with diabetes mellitus
- (2021) Wenxing Yang et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Pre-admission glucagon-like peptide-1 receptor agonist (GLP-1RA) and mortality from coronavirus disease 2019 (Covid-19): A systematic review, meta-analysis, and meta-regression
- (2021) Timotius Ivan Hariyanto et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Risk factors for COVID-19 hospitalisation and death in people living with diabetes: A virtual cohort study from the Western Cape Province, South Africa
- (2021) Joel A. Dave et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Predictors of Severe COVID-19 in Patients With Diabetes: A Multicenter Review
- (2021) Megan M. Kristan et al. Endocrine Practice
- Effects of metformin, insulin on COVID-19 patients with pre-existed type 2 diabetes: A multicentral retrospective study
- (2021) Xueqi Cheng et al. LIFE SCIENCES
- DPP-4 inhibitors may improve the mortality of coronavirus disease 2019: A meta-analysis
- (2021) Yan Yang et al. PLoS One
- Outcome and death risk of diabetes patients with Covid-19 receiving pre-hospital and in-hospital metformin therapies
- (2021) Rodrigo Esaki Tamura et al. Diabetology & Metabolic Syndrome
- Diabetes and coronavirus (SARS-CoV-2): Molecular mechanism of Metformin intervention and the scientific basis of drug repurposing
- (2021) Elizabeth Varghese et al. PLoS Pathogens
- Lower COVID-19 Mortality in Patients with Type 2 Diabetes Mellitus Taking Dipeptidyl Peptidase-4 Inhibitors: Results from a Turkish Nationwide Study
- (2021) Rifat Emral et al. Diabetes Therapy
- Risk Factors Associated with COVID-19 Hospitalization and Mortality: A Large Claims-Based Analysis Among People with Type 2 Diabetes Mellitus in the United States
- (2021) Kristina S. Boye et al. Diabetes Therapy
- Mortality Risk of Antidiabetic Agents for Type 2 Diabetes With COVID-19: A Systematic Review and Meta-Analysis
- (2021) Chengxia Kan et al. Frontiers in Endocrinology
- Metformin Use Is Associated with Decreased Mortality in COVID-19 Patients with Diabetes: Evidence from Retrospective Studies and Biological Mechanism
- (2021) Tahmina Nasrin Poly et al. Journal of Clinical Medicine
- Dipeptidyl Peptidase-4 Inhibitors and COVID-19-Related Deaths among Patients with Type 2 Diabetes Mellitus: A Meta-Analysis of Observational Studies
- (2021) Dimitrios Patoulias et al. Endocrinology and Metabolism
- Diabetes, Drug Treatment, and Mortality in COVID-19: A Multinational Retrospective Cohort Study
- (2021) Jennifer E. Nyland et al. DIABETES
- Prior Glucose-Lowering Medication Use and 30-Day Outcomes Among 64,892 Veterans With Diabetes and COVID-19
- (2021) Pandora L. Wander et al. DIABETES CARE
- From swab testing to health outcomes within the T2DM population: Impact of diabetes background on COVID19 progression
- (2021) Carlo Bruno Giorda et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Factors influencing on development of COVID-19 pneumonia and association with oral anti-diabetic drugs in hospitalized patients with diabetes mellitus
- (2021) Ayça Elibol et al. Primary Care Diabetes
- Diabetes patients with comorbidities had unfavorable outcomes following COVID-19: A retrospective study
- (2021) Shun-Kui Luo et al. World Journal of Diabetes
- Association Between Metformin Use and Mortality Among Patients with Type 2 Diabetes Mellitus Hospitalized for COVID-19 Infection
- (2021) Angeli Nicole Ong et al. Journal of the ASEAN Federation of Endocrine Societies
- Metformin Treatment Was Associated with Decreased Mortality in COVID-19 Patients with Diabetes in a Retrospective Analysis
- (2020) Pan Luo et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Clinical Characteristics and Outcomes of Patients With Diabetes and COVID-19 in Association With Glucose-Lowering Medication
- (2020) Yuchen Chen et al. DIABETES CARE
- Exposure to DPP ‐4 inhibitors and COVID ‐19 among people with type 2 diabetes. A case–control study
- (2020) Gian Paolo Fadini et al. DIABETES OBESITY & METABOLISM
- Coronavirus Infections and Type 2 Diabetes—Shared Pathways with Therapeutic Implications
- (2020) Daniel J Drucker ENDOCRINE REVIEWS
- Clinical characteristics and outcomes of patients with severe covid-19 with diabetes
- (2020) Yongli Yan et al. BMJ Open Diabetes Research & Care
- Metformin and COVID-19: From cellular mechanisms to reduced mortality
- (2020) A.J. Scheen DIABETES & METABOLISM
- Preadmission Diabetes-Specific Risk Factors for Mortality in Hospitalized Patients With Diabetes and Coronavirus Disease 2019
- (2020) Shivani Agarwal et al. DIABETES CARE
- Metformin in COVID-19: A possible role beyond diabetes
- (2020) Swati Sharma et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- A tertiary center experience of multiple myeloma patients with COVID-19: lessons learned and the path forward
- (2020) Bo Wang et al. Journal of Hematology & Oncology
- Metformin Is Associated with Higher Incidence of Acidosis, but Not Mortality, in Individuals with COVID-19 and Pre-existing Type 2 Diabetes
- (2020) Xu Cheng et al. Cell Metabolism
- Impact of Comorbidities and Glycemia at Admission and Dipeptidyl Peptidase 4 Inhibitors in Patients With Type 2 Diabetes With COVID-19: A Case Series From an Academic Hospital in Lombardy, Italy
- (2020) Marco Mirani et al. DIABETES CARE
- Use of DPP4 inhibitors in Italy does not correlate with diabetes prevalence among COVID-19 deaths
- (2020) Rocky Strollo et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Mortality risk with preadmission metformin use in patients with COVID‐19 and diabetes: A meta‐analysis
- (2020) Chia Siang Kow et al. JOURNAL OF MEDICAL VIROLOGY
- Metformin is associated with Decreased 30-day Mortality among Nursing Home Residents Infected with SARS-CoV2
- (2020) Michelle Lally et al. Journal of the American Medical Directors Association
- Are diabetes and its medications risk factors for the development of COVID-19? Data from a population-based study in Sicily
- (2020) Silverii Giovanni Antonio et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- Mortality and other adverse outcomes in patients with type 2 diabetes mellitus admitted for COVID-19 in association with glucose-lowering drugs: a nationwide cohort study
- (2020) Luis M. Pérez-Belmonte et al. BMC Medicine
- COVID‐19 fatality prediction in people with diabetes and prediabetes using a simple score upon hospital admission
- (2020) Harald Sourij et al. DIABETES OBESITY & METABOLISM
- Insulin Use, Diabetes Control, and Outcomes in Patients with COVID-19
- (2020) Shayan Riahi et al. ENDOCRINE RESEARCH
- Anti-Inflammatory Effects of GLP-1-Based Therapies beyond Glucose Control
- (2016) Young-Sun Lee et al. MEDIATORS OF INFLAMMATION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now